» Articles » PMID: 37937070

The Influence of Physiological and Pathological Perturbations on Blood-brain Barrier Function

Overview
Journal Front Neurosci
Date 2023 Nov 8
PMID 37937070
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is located at the interface between the vascular system and the brain parenchyma, and is responsible for communication with systemic circulation and peripheral tissues. During life, the BBB can be subjected to a wide range of perturbations or stresses that may be endogenous or exogenous, pathological or therapeutic, or intended or unintended. The risk factors for many diseases of the brain are multifactorial and involve perturbations that may occur simultaneously (e.g., two-hit model for Alzheimer's disease) and result in different outcomes. Therefore, it is important to understand the influence of individual perturbations on BBB function in isolation. Here we review the effects of eight perturbations: mechanical forces, temperature, electromagnetic radiation, hypoxia, endogenous factors, exogenous factors, chemical factors, and pathogens. While some perturbations may result in acute or chronic BBB disruption, many are also exploited for diagnostic or therapeutic purposes. The resultant outcome on BBB function depends on the dose (or magnitude) and duration of the perturbation. Homeostasis may be restored by self-repair, for example, via processes such as proliferation of affected cells or angiogenesis to create new vasculature. Transient or sustained BBB dysfunction may result in acute or pathological symptoms, for example, microhemorrhages or hypoperfusion. In more extreme cases, perturbations may lead to cytotoxicity and cell death, for example, through exposure to cytotoxic plaques.

Citing Articles

Assessing Mild Traumatic Brain Injury-Associated Blood-Brain Barrier (BBB) Damage and Restoration Using Late-Phase Perfusion Analysis by 3D ASL MRI: Implications for Predicting Progressive Brain Injury in a Focused Review.

Joseph C Int J Mol Sci. 2024; 25(21).

PMID: 39519073 PMC: 11547134. DOI: 10.3390/ijms252111522.


Nanomedicine in Neuroprotection, Neuroregeneration, and Blood-Brain Barrier Modulation: A Narrative Review.

Krsek A, Jagodic A, Baticic L Medicina (Kaunas). 2024; 60(9).

PMID: 39336425 PMC: 11433843. DOI: 10.3390/medicina60091384.


Central nervous system manifestations in rheumatic diseases.

Smiyan S, Komorovsky R, Koshak B, Duve K, Shkrobot S Rheumatol Int. 2024; 44(10):1803-1812.

PMID: 39136787 DOI: 10.1007/s00296-024-05679-1.


Progressive Age-Associated Blood-Brain Barrier Leak/Dysfunction-Nexus of Neurodegenerative Disease Using MRI Markers to Identify Preclinical Disease and Potential New Targets for Future Treatments.

Joseph C Diagnostics (Basel). 2024; 14(7).

PMID: 38611639 PMC: 11011559. DOI: 10.3390/diagnostics14070726.


Erythrocyte glycocalyx sensitivity to sodium is associated with salt sensitivity of blood pressure in women but not men.

Masenga S, Hamooya B, Patel K, Kirabo A Front Nutr. 2024; 11:1334853.

PMID: 38524849 PMC: 10957757. DOI: 10.3389/fnut.2024.1334853.

References
1.
Coelho-Santos V, Leitao R, Cardoso F, Palmela I, Rito M, Barbosa M . The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction. J Cereb Blood Flow Metab. 2015; 35(8):1260-71. PMC: 4528012. DOI: 10.1038/jcbfm.2015.59. View

2.
Mishani S, Belhoul-Fakir H, Lagat C, Jansen S, Evans B, Lawrence-Brown M . Stress distribution in the walls of major arteries: implications for atherogenesis. Quant Imaging Med Surg. 2021; 11(8):3494-3505. PMC: 8245957. DOI: 10.21037/qims-20-614. View

3.
Sharma H, Dey P . Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology. 1986; 25(2):161-7. DOI: 10.1016/0028-3908(86)90037-7. View

4.
Lin E . Radiation risk from medical imaging. Mayo Clin Proc. 2010; 85(12):1142-6. PMC: 2996147. DOI: 10.4065/mcp.2010.0260. View

5.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View